William  Torrey

Dr. William Torrey


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2018 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
YZYaara Zisman-Ilani
Yaara Zisman-Ilani
DSDavid Shern
David Shern
PDPatricia Deegan
Patricia Deegan
JKJulie Kreyenbuhl
Julie Kreyenbuhl
LDLisa Dixon
Lisa Dixon
GEGlyn Elwyn
Glyn Elwyn
People with psychosis struggle with decisions about their use of antipsychotics. They often want to reduce the dose or stop, while facing uncertainty regarding the effects these decisions will have on their treatment and recovery. They may also fear raising this issue with clinicians. The purpose of this study was to develop and test a shared decision making (SDM) tool to support patients and clinicians in making decisions about antipsychotics. A diverse editorial research team developed an Encounter Decision Aid (EDA) for patients and clinicians to use as part of the psychiatric consultation. The EDA was tested using 24 semistructured interviews with participants representing six stakeholder groups: patients with first-episode psychosis, patients with long-term psychosis, family members, psychiatrists, mental health counselors, and administrators. We used inductive and deductive coding of interview transcripts to identify points to revise within three domains: general impression and purpose of the EDA; suggested changes to the content, wording, and appearance; and usability and potential contribution to the psychiatric consultation. An EDA was developed in an iterative process that yielded evidence-based answers to five frequently asked questions about antipsychotic medications. Patients with long-term psychosis and mental health counselors suggested more changes and revisions than patients with first-episode psychosis and psychiatrists. Family members suggested more revisions to the answers about potential risks of stopping or adjusting antipsychotics than other respondents. The EDA was perceived as potentially useful and feasible in psychiatric routine care, especially if presented during the consultation.

4 March 2021 in Community Mental Health Journal
Verified
Journal Article
Closed access
PDF file
CSC. L. Shannon
C. L. Shannon
SBS. M. Bartels
S. M. Bartels
MCM. Cepeda
M. Cepeda
SCS. Castro
S. Castro
LCL. Cubillos
L. Cubillos
WTWilliam Torrey
William Torrey




1 July 2020 in Psychiatric Services
Verified
Journal Article
Closed access
WTWilliam Torrey
William Torrey